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Summary 
 
The assessment of radiolucency around an implant is qualitative, poorly defined, and has low 
agreement between clinicians.  Accurate and repeatable assessment of radiolucency is essential to 
prevent misdiagnosis, minimise cases of unnecessary revision, and to correctly monitor and treat 
patients at risk of loosening and implant failure.  The purpose of this study was to examine whether a 
semi-automated imaging algorithm could improve repeatability, and enable quantitative assessment of 
radiolucency.  Six surgeons assessed 38 radiographs of knees after unicompartmental knee 
arthroplasty for radiolucency, and results were compared with assessments made by the semi-
automated program.  Large variation was found between the surgeon results, with total agreement in 
only 9.4% of zones and a Kappa value of 0.602; whereas the automated program had total agreement 
in 81.6% of zones and a Kappa value of 0.802.  The software had a ‘fair to excellent’ prediction of the 
presence or absence of radiolucency, where the area under the curve (AUC) of the receiver operating 
curves (ROC) was 0.82 on average.  The software predicted radiolucency equally well for cemented, 
and cementless implants (p=0.996).   The identification of radiolucency using an automated method is 
feasible and these results indicate it could aid in the definition and quantification of radiolucency.  
 
Keywords 
Radiolucency, Knee, Measurement, Reliability 
 
Introduction 
 
After arthroplasty, radiolucent lines can often be observed on radiographs surrounding implanted 
components.  The lines are normally noted within 1 year of implantation, but can develop up to 2 
years after implantation [1].  There is sometimes a misconception among surgeons that the presence 
of radiolucency around an implant is always indicative of loosening [2-4].  However, Goodfellow et 
al. noted that the presence of a radiolucency does not always indicate that implant loosening will 
occur; the authors described two types of radiolucency, pathological, or physiological [1].  
Pathological radiolucent lines increase in thickness with time, and are generally more than 2 mm thick 
and are indicative of a problem such as infection or loosening [1, 5].  Physiological radiolucent lines 
are generally well defined with a sclerotic margin, non-progressive, less than 2 mm thick, and are not 
indicative of loosening [1, 5].  It is, therefore, important to correctly distinguish between pathological 
and physiological radiolucent lines, to ensure that unnecessary revision of well-fixed components 
does not occur [2-4]. 
 
The positive identification of a radiolucent line within a radiograph is generally performed visually by 
clinicians.  The process can be subjective, the experience and speciality of the clinicians performing 
the assessment can vary, and accurate detection relies upon high quality radiographs.  Surgeons are 
not trained formally in how to identify radiolucency at any stage of their training, and there are no 
guidelines on how it should be done.  In practice, clinical judgement will not only be influenced by 
the presence of a radiolucent region on a radiograph, but also by the reported patient symptoms and 
by observing how the observed radiolucency changes with time. 
 
It is important to control the angle at which the radiograph is taken, as the implant may obscure the 
radiolucency; fluoroscopically guided radiographs have been shown to be the most accurate 
measurement method [6], however, these are not always used [7].  McCaskie et al. examined the 
reliability of detecting radiolucencies within hip radiographs and found that there was wide variation 
in the agreement between the raters, and this was equally variable for experienced as well as 
inexperienced clinicians [8].  In addition, it has been shown that surgeons are unable to reliably detect 
radiolucent lines less than 0.7 mm thick [9]. 
 
In order to ensure the early identification of progressive radiolucency and to minimise misdiagnosis 
leading to unnecessary revision of implants with physiological radiolucencies, it is important that the 
measurement of radiolucencies is standardised and the reliability improved.  Kobayashi et al. defined 
radiolucency as being “radiolucency surrounded by lines of increased density” [10, 11].  By using this 
definition it is possible to automate the analysis of radiolucent lines, using image processing 
techniques.  By using a computerised process, the subjectivity of the assessor is removed, and more 
quantitative results can be obtained. 
 
There is evidence that it is more difficult to distinguish between a physiological radiolucent line and a 
pathological one after unicompartmental knee arthroplasty (UKA) [12].  The consequence of such 
misdiagnosis may be the unnecessary revision of the component.  It is known that the revision rate 
after UKA is significantly higher than total knee arthroplasty (TKA) [13], and it is possible that poor 
identification of radiolucency may be a factor. 
 
For this reason, the purpose of this study was to examine the feasibility of using an automated 
computer program to help standardise the measurement of radiolucency after UKA. The study aimed 
to (1) quantify the variability between surgical identification of radiolucency, (2) compare the results 
of the automated procedure with the average surgical consensus, (3) examine whether the software 
algorithm was robust enough to cope with cemented as well as cementless components and (4) use the 
software to create a quantifiable definition of radiolucency around a UKA. 
 
Methodology 
 
Image preparation 
Thirty-eight fluoroscopy-screened radiographs [1] were examined from patients who had undergone 
UKA  at the Nuffield Orthopaedic Centre in Oxford.  The radiographs were from an on-going 
randomised control trial investigating cementless, and cemented, implant migration using 
Radiostereometric Analysis (RSA) in 40 patients; ethical approval was attained with informed consent 
to use the radiographs (Oxford REC B in 2002, reference C01-101).  All patients had been implanted 
with the medial Oxford UKA (Biomet UK Ltd., Swindon, UK), and the radiographs were taken within 
2 years of implantation.  Of the 38 images, 19 were of cementless implants and 19 were of cemented 
components.  
 
Manual Assessment of Radiolucency 
The radiographs were visually assessed for radiolucency by six orthopaedic surgeons.  The surgeons 
were all either orthopaedic registrars or orthopaedic consultants.  The surgeons were provided with 
the radiographs in JPEG file format which had been exported from the PACS hospital system 
software (average image resolution of 183.6 DPI ± 20.5) and a Microsoft Excel-based form to enter 
their data.  Each surgeon then assessed the radiographs for radiolucency in their own time on 
computers of their choice; all the computers chosen were office-based systems.  The tibial tray was 
considered to be divided into seven zones, previously defined by Hooper et al. [14] (Figure 1), and the 
surgeon recorded whether radiolucency was present or not in each zone. In order to best reproduce the 
clinical situation, the surgeons were not given any guidance as to how to identify radiolucency within 
the zones; they were just presented with the radiographs, and a form to complete containing an image 
illustrating the location of the zones. 
 
Semi-Automatic Radiolucent Area Quantification (SARAQ) 
The SARAQ program was created to automate assessment of radiolucency and was written in 
MATLAB (Version 2010a, MathWorks Inc. Natick, MA, USA). The radiograph images were 
processed in three stages.  Firstly, the program identified where the tibial tray was in the radiograph 
by iterating from a user-defined start point; secondly, the change in greyscale normal to the tray was 
recorded; finally the series of greyscale profiles were analysed and the presence of radiolucency 
assessed. In order to get an idea of the intra-observer reliability of the SARAQ software, all 
radiographs were processed six times. 
 
To locate the tibial tray within the image, a technique called active shape modelling was used, which 
was originally described by Cootes et al.[15].  The method involves first ‘training’ the model, where 
specific landmarks on a range of similar images are manually selected.  Please note, training of the 
model need only be performed once to define the shape for the model parameters for any given type 
of implant; once defined, the model could be run on as many images as required without re-training 
the model.  The training information was processed to record the expected shape and intensity profile 
for the particular application.  For the present study, an active shape model which had been previously 
validated for the Oxford UKA was used [16].   
 
The model was trained on 36 training radiographs; if necessary, images were flipped to ensure that the 
implanted side was on the right-hand side of the image.  Fifty-three landmark points surrounding the 
tibial tray were then manually selected for each training image (this process took approximately 15 
minutes per image); these points were then interpolated to give a total of 989 co-ordinates.  All shapes 
were aligned using the Procrustes method [17]; the shapes were then translated so that the centroid of 
the shape was at the origin; rotation effects were removed by using the mean angle to the centroid, 
finally scaling was removed by normalising the image by the tibial width [16].  Principal component 
analysis was then performed on the training data shape co-ordinates, and the greyscale profiles (12 
pixels long) normal to each point and the greyscale differences in the profiles which were normalised 
by the average profile.  Once this process was completed and the shape model had been defined for 
the shape of the UKR, the shape model could then be applied to numerous radiographs to locate the 
tibial tray.  Further information on the definition and validation of the model has been described in a 
previous publication [16]; the study demonstrated measurements taken with the shape model were 
significantly quicker, had equivalent accuracy and higher reliability than manual measurements. 
 
To run the model on a radiograph, the user inputted the starting position, and then the software 
performed 40 iterations to find the final shape which best correlated with the training data. 
Radiographic magnification was calculated using the spherical femoral component as a reference 
value to perform the calibration between image and real-world dimensions; points circling the femoral 
component were found using edge detection, and then a circle was fitted using a least-squares 
algorithm [16]. 
 
Once the region of the tibial tray within the image had been identified, the image was cropped to just 
include the proximal tibia, and resized to a 700x700 pixel resolution for consistency.  The greyscale 
profiles emanating perpendicular to the tray through the bone over a distance of 50 pixels were then 
recorded.  Due to the landmark point definition of the shape model, the locations of corners of the 
tibial tray were known and therefore the profiles could be split into the relevant zones (Figure 2).  The 
profiles were then normalised to minimise any effects from radiographic intensity; the maximum 
intensity (implant region) was set to 1, and the minimum intensity to zero. 
 
Each individual profile was examined for radiolucency.  All profiles were smoothed using a local 
regression with a weighted linear least squares and a 1
st
 degree polynomial model (LOWESS), to 
reduce scatter and emphasise trends.  Radiolucency was deemed to be present where there was a dip 
in the greyscale intensity, followed by a rise of sufficient height (Figure 3).  The height difference was 
required to be more than 5% of the maximum greyscale intensity within the zone; otherwise the 
radiolucency was not recorded.  The width of the radiolucent line was defined as the distance along 
which the intensity was in the lower half of the intensity of the radiolucent region (i.e. the mean 
intensity of the dip and the peak). 
 
For a particular zone, the distance (in millimetres) between the peaks of each profile defined as being 
radiolucent was averaged to give the average width of the radiolucent line.  The width was then 
multiplied by the length over which the line was present, to give a radiolucent “area” in millimetres 
squared.  The radiolucent area was then used as a score to define whether or not radiolucency was 
present within the zone.   
 
Statistical Analysis 
To quantify how well the SARAQ software predicted the surgical assessment of radiographs, receiver 
operating characteristic (ROC) analysis was performed using the pROC package in R [18] (version 
2.15.1, http://www.r-project.org).  The areas under the curve (AUC) results were analysed using the 
guidelines from Haase-Fielitz et al. [19] where; 0.9-1.0 indicates an excellent prediction, 0.80-0.89 
good, 0.70-0.79 fair, 0.60-0.69 poor, and 0.50-0.59 no useful value.  DeLong’s statistical test was 
used to determine whether there was a statistical difference between each individual surgeon’s AUC 
result and that of the entire combined dataset [20].  The AUCs were calculated and compared for; 
each individual surgeon and the combined dataset; cemented versus cementless radiographs, and each 
individual radiographic zone.  The prevalence of radiolucency in the cemented and cementless 
radiographs was also examined using a Chi-squared test.  The optimum SARAQ area threshold values 
(mm
2
), above which a radiographic zone would be defined as being radiolucent, were calculated from 
the ROC curves for each radiographic zone using the Youden method [21].  
 
The reliability of the manual and semi-automatic measurement methods was compared.  Agreement 
between the surgical ratings of radiolucency was assessed using the Fleiss Kappa statistic [22] with 
the guidelines detailed by Landis and Koch [23]; where Kappa values <0 indicated poor agreement, 0-
0.20 slight agreement, 0.21-0.40 fair agreement, 0.41-0.60 moderate agreement, 0.61-0.80 substantial 
agreement, and more than 0.81 to be almost perfect agreement. The software reliability was assessed 
using two methods; the Fleiss Kappa statistic and the Intraclass Correlation Coefficient (ICC).  The 
Kappa statistic was calculated to examine how reliable the SARAQ software was in detecting the 
presence or absence of radiolucency (binary data); the presence or absence was calculated using the 
threshold values calculated using the Youden method.  The Intraclass Correlation Coefficient (ICC) 
was calculated to assess the reliability of the radiolucency area measurement (continuous data) and 
radiolucency thickness measurement (continuous data); a two-way mixed model with single measures 
was used.   
 
Results 
 
The AUC values for how well the SARAQ software predicted the combined surgeon results and the 
individual surgeon results were examined (Figure 4).  The AUC values varied from 0.75 to 0.93 
depending on the surgeon (Figure 5); this represents a fair to excellent prediction.  The AUC of the 
combined dataset was 0.82 (95% CI: 0.75-0.88).  When the individual surgeon ROC curve areas were 
compared statistically against the combined dataset, five of the six were not statistically different, but 
one was significantly higher (p<0.0001) than the combined dataset. 
 
Out of the zones where the SARAQ software identified radiolucency, the average thickness was 1.05 
mm with a standard deviation of 0.50 mm; the maximum thickness measured was 2.71 mm (Figure 6).   
 
The ROC curves examining the results from radiographs of cemented and cementless components 
were similar (Figure 7).  The AUC for the cemented results was 0.824 (CI: 0.740-0.908), and for the 
cementless results was 0.857 (CI: 0.762-0.952), and statistically no significant difference was found 
between the two (p=0.996).  Of the radiographs examined, a lower incidence of radiolucency was 
found for the cementless components (surgeons determined radiolucency to be present in 21.2% of the 
cementless zones) compared with the cemented components (radiolucency present in 30.3% of the 
cemented zones); this difference was significant (p = 0.028). 
 
The SARAQ software demonstrated varying accuracy in predicting radiolucency in different zones; 
AUC values ranged from 0.60 (zone 4, CI: 0.45-0.74) to 0.82 (zone 7 CI: 0.76-0.89).  The estimated 
threshold value for the optimum cut-off for prediction of radiolucency were different for each zone 
(Table 1); the lowest threshold was found for zone 5 at 0.0075 mm
2
, and the highest was for zone 4 at 
0.0594 mm
2
.  The calculated threshold for the entire dataset was 0.0266 mm
2
.  Pair-wise comparisons 
showed that the AUC for zone 7 was statistically different to zone 1 (p=0.015), zone 4 (p=0.006) and 
zone 6 (p=0.002); no other differences were found between the zones. 
 The Kappa statistic calculated for the surgeon agreement was 0.602 (p < 0.0001).  According to 
Landis and Koch’s definition, this represents a substantial agreement.  However, out of the 38 
radiographs examined, the surgeons were in absolute agreement for only 25 zones out of the 266 
measured, which is 9.4%.  The Kappa statistic calculated for the SARAQ software agreement was 
0.802 (p<0.0001) which is very close to being an ‘almost perfect agreement’ ( > 0.81) as defined by 
Landis and Koch, and the SARAQ software was in absolute agreement for 217 zones of the 266 
measured which is 81.6%. The ICC for the software thickness measurements was 0.704, and for the 
software area results was 0.881,  representing good to excellent reliability for both measurements 
(perfect reliability = 1).   
 
Discussion 
 
Although radiographs are routinely examined for the presence of radiolucency, there is a surprising 
lack of guidance on how to define radiolucency.  Kobayashi’s definition, that a radiolucency must 
consist of a radiolucent line surrounded by lines of increased density [10], is clear; but it is a 
qualitative description which is open to interpretation.  The variation in surgical assessment of 
radiolucency in the present study was relatively large, with the surgeons only being in total agreement 
for 9.4% of the measurements; however, the Kappa statistic (0.602) indicated substantial agreement 
according to Landis and Koch’s definition.  The surgeon agreement found in the present study is 
greater than that reported by McCaskie et al. [8].  McCaskie et al. examined radiolucency 
measurement reliability in different regions of hip radiographs; Kappa values ranged from -0.520 to 
0.373.  From these data overall, it can be concluded that there is a clinical need for a more reliable 
method to measure radiolucency after joint replacement.   
 
The reliability of the SARAQ software was shown to be higher than the surgical assessment of 
radiolucency in terms of the Kappa statistic (0.802), and also the software was found to be in absolute 
agreement for 82% of the zones which was far greater than the 9.4% of absolute agreement from the 
surgeons.  The resolution of the radiographs analysed in this study was relatively low (183.6 DPI), 
however this represents the quality of radiographs which would be routinely assessed clinically.  The 
resolution was limited by the clinical requirement to minimise patient radiation levels and also 
compounded by the small size of the unicompartmental knee replacement; yet despite this the 
SARAQ software was able to reliably analyse the radiographic images, which was encouraging.  The 
reason the software was not in perfect agreement when run multiple times was due to the variation in 
the manually assigned start position for the active shape model, resulting in slightly different profiles 
each time the software was run.  This result demonstrates the SARAQ software provided improved 
reliability to the surgical assessment and previous work has shown the software takes only 2 minutes 
to analyse one radiograph so its use clinically would be viable [16]; however, reliability is of no use 
without accuracy. 
 
The SARAQ software demonstrated promising results in terms of accuracy of radiolucency 
assessment; the software had an average AUC value of 0.82 which represents a ‘good’ agreement 
between the surgical assessment and the software assessment.  The majority of radiolucency 
thicknesses measured by the SARAQ software were below 2 mm, indicating these were physiological 
radiolucencies; this correlates well with the literature [1, 12].  Some thicker pathological 
radiolucencies were measured, but none exceeded 3 mm, which was in accordance with Tibrewal et 
al. [1] who also found that radiolucencies did not exceed 3 mm.   
 
There was a concern that the effectiveness of the SARAQ software in predicting radiolucency would 
differ for cemented versus cementless implants due to the radio-opaque nature of the cement 
influencing the algorithm.  However, the ROC curve results demonstrated that there was no 
significant difference between the AUC values for the two implant designs, and visually the ROC 
curves were similar (Figure 7).  To positively identify a radiolucency, the software needs to detect a 
decrease in the brightness of the profile followed by a subsequent increase; because the cement is 
more radiolucent that the bone the definition will work appropriately for both cemented and 
cementless components.  However, this study has not considered whether the algorithm would be able 
to detect radiolucency in cases where radiolucent bone cement had been used; in addition, if there was 
debonding of the cement from the implant, the algorithm may misinterpret this as a radiolucency.  The 
results of the study also showed a greater incidence of radiolucency for the cemented components 
compared with the cementless components, which correlates with other studies reported in the 
literature [24]. 
 
It is known that for the unicompartmental tibial tray, that some zones are more likely to be radiolucent 
than others [5].  For this reason, the radiolucency and cut-off thresholds were assessed for particular 
zones around the tray.  Wide variation was found in the AUC values from the ROC curves for each 
zone, ranging from 0.59 to 0.82; however, only zone 7 was significantly different to other zones, 
indicating the range in AUC was largely due to a manifestation of background intensity variability 
across the radiographs, rather than representing real differences in the zones.   
 
The AUC of zone 7 was significantly higher than the other zones; zone 7 is next to the wall of the 
tray, and is different from the other zones in that it is not axially loaded, cement is not applied to the 
zone [5], and in the case of cementless components, porous titanium coating is not present on the tray 
wall.  The difference observed may be a consequence of these reasons, alternatively it may relate to a 
bony response to high stresses in the corner of the tibial tray [25, 26]. 
 The present study has several limitations.  The surgeons were given no guidance on how to identify 
radiolucent regions around the implant therefore the study was not controlled; however, this does 
represent the clinical situation where surgeons have been shown to use different assessment criteria 
for radiolucency.  In addition, the surgeons were not guided on the monitor quality on which to 
perform their assessment of the radiographs; and monitor quality has been shown to be influential in 
radiographic assessment.  The SARAQ software has been assessed in this study on only one single 
type of implant.  The Oxford UKA has a unique design with a flat tibial implant surface which 
enables the bone-implant interface to be clearly imaged, provided that the radiograph is properly 
screened.  This may not be possible with other joint replacement designs; therefore, whether the 
SARAQ software would work equally well on other designs has yet to be confirmed.  In addition, the 
process of selecting the landmark points for the training data is time-consuming; therefore this method 
may not be suitable for studies comparing many different shapes/designs.  As previously mentioned, it 
is yet unconfirmed as to whether the algorithm is able to identify a radiolucency in a radiograph 
containing radiolucent cement, and it is also likely that the software is unable to distinguish between 
cement debonding and radiolucency.  Radiolucent cement is rarely used; therefore this is not expected 
to be a common issue.  Cases of cement debonding are more common but it is important to note that 
the treatment for severe radiolucency and cement debonding are the same.  When the individual zones 
were examined separately in this study, the sample size was too low to draw any conclusions on 
differences between the zones, with the exception of zone 7; a larger research study is underway to 
refine and optimise the program for specific zones.  
  
Nevertheless, this study is promising and indicates that automated measurements of radiolucency 
could be a useful addition to clinical observance.  The wide variation found in the surgical assessment 
of radiolucency was concerning, and a digital computerised tool may be the solution to enable 
standardisation and quantification of clinical radiolucency assessment.  Such a tool may help to ensure 
that patients with progressive radiolucencies can be identified early and monitored using a reliable, 
quantitative method. 
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Figure captions 
Figure 1.  A schematic illustration of the position of the seven defined zones surrounding the tibial 
implant. 
Figure 2.  An example of the greyscale profiles from each zone of a radiograph after processing. 
Figure 3.  Example of a smoothed greyscale profile of a radiolucent region, an image of the 
radiograph from which the profile was taken is shown and the profile is illustrated by a black line.  
The value h represents the difference in height between the second peak (more radiodense line) and 
the minimum of the dip prior to it (the radiolucent line).  The value t represents the thickness of the 
radiolucent line. 
Figure 4. ROCs illustrating the diagnostic capability of the radiolucent area parameter output by the 
software in predicting radiolucency as defined by the average data from the six surgeons, and the 
curves for each surgeon individually. 
Figure 5.  Summary of the AUC results calculated from the ROC curves for the six surgeons; error 
bars represent the 95% confidence intervals. 
Figure 6.  Boxplot of the distribution of the thickness of radiolucent lines measured by the automated 
program. 
Figure 7.  ROC curves for results from cemented and cementless components.  No significant 
difference was found between the ROC curve areas (p=0.97). 
 
Tables 
 
Zone AUC 95% CI AUC Threshold (mm
2
) 
lower upper 
1 0.683 0.593 0.773 0.0189 
2 0.765 0.660 0.871 0.0232 
3 0.713 0.611 0.814 0.0294 
4 0.596 0.452 0.741 0.0532 
5 0.704 0.615 0.793 0.0075 
6 0.668 0.594 0.742 0.0085 
7 0.821 0.757 0.886 0.0281 
Table 1. Summary of the AUC values measured for different zones and the estimated threshold for 
radiolucency area within each zone. 
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